The Failure of the Covid Vaxxes By Brian Simpson

The present state of affairs on the Covid vax frontier is that the vaxxes are failures, failing to prevent the covid virus from spreading. As detailed below, this failure was present in the beginning, as the initial clinical trials did not prove that the vaccines actually worked beyond mild cases of Covid. Dr. Peter Doshi of the University of Maryland School of Pharmacy and Scripps Research Translational Institute Director Eric Topol in  a New York Times opinion article published September 22, 2020, noted this: “If you were to approve a coronavirus vaccine, would you approve one that you knew protected people only from the most mild form of COVID-19, or one that would prevent its serious complications? The answer is obvious. You would want [the vaccine] to protect against the worst cases,” the article said. “But that’s not how the companies testing three of the leading coronavirus vaccine candidates, Moderna, Pfizer and AstraZeneca, whose U.S. trial is on hold, are approaching the problem.” The vaxxes dealt only with mild cases of Covid.

https://www.naturalnews.com/2022-01-28-covid-vaccines-are-doomed-to-fail.html

“The Wuhan coronavirus (COVID-19) vaccines made by Pfizer, AstraZeneca and Moderna do not prevent the SARS-CoV-2 virus from spreading.

This was proven by vaccine clinical trials and supported by what’s happening in the real world. The reality is, nothing has changed since the jabs were introduced. The vaccine makers have also designed a series of clinical trials that were bound to be a complete flop.

In a New York Times opinion article published September 22, 2020, Dr. Peter Doshi of the University of Maryland School of Pharmacy and Scripps Research Translational Institute Director Eric Topol discussed the flaws in the clinical trials conducted by Pfizer, AstraZeneca and Moderna.

The most glaring flaw was that the trials didn’t answer the question of whether the vaccines are able to protect people and prevent serious complications.

“If you were to approve a coronavirus vaccine, would you approve one that you knew protected people only from the most mild form of COVID-19, or one that would prevent its serious complications? The answer is obvious. You would want [the vaccine] to protect against the worst cases,” the article said.

“But that’s not how the companies testing three of the leading coronavirus vaccine candidates, Moderna, Pfizer and AstraZeneca, whose U.S. trial is on hold, are approaching the problem.”

COVID vaccines only effective at preventing “mild cases of COVID”

The article noted that, according to the protocols for the studies released in September 2020, “a vaccine could meet the companies’ benchmark for success if it lowered the risk of mild COVID-19, but was never shown to reduce moderate or severe forms of the disease, or the risk of hospitalization, admissions to the intensive care unit or death.”

“To say a vaccine works should mean that most people no longer run the risk of getting seriously sick. That’s not what these trials will determine,” the article stated.

This could only mean that the clinical trials were designed to display effectiveness in preventing “mild cases of COVID” but not the moderate or severe cases of the disease. It further showed that the vaccine clinical trials were completely useless and irrelevant and were done in a misleading and deceptive way.

The Moderna and AstraZeneca studies involved about 30,000 participants each while Pfizer had 44,000. Half the participants got two doses of vaccines separated by three or four weeks while the other half received saltwater placebo shots. The final determination of efficacy for the vaccines took place after 150 to 160 participants developed COVID-19.

However, the Moderna and Pfizer trials considered a cough plus a positive lab test to be a mild case of COVID-19. This qualification eventually muddied the test results. AstraZeneca, on the other hand, was stricter; but it still counted mild symptoms like a cough plus fever as a COVID-19 case.

Studies have shown that up to 90 percent of COVID-19 cases are false positives because the PCR test is too sensitive and registers “positive for COVID” when it shouldn’t. This means that the vaccine clinical trials’ process of determining the efficacy of the vaccines “after 150 to 160 people developed COVID-19” was utterly deceptive, useless and ridiculous. A positive PCR test is too unreliable and meaningless.

Pfizer, Moderna to begin omicron clinical trials

Meanwhile, both Pfizer and Moderna recently announced that they have begun clinical trials testing omicron-specific formulations of their mRNA COVID-19 vaccines.

Data from the trials are expected to emerge in the first half of 2022, but some experts  hint that end of the year may be too late for omicron vaccines as the world could be dealing with new variants by then.

Pfizer was the first to announce the start of large clinical trials testing an omicron-specific mRNA vaccine. The plan is to enlist 1,420 participants dispersed across three groups.

The largest group, which has 615 subjects, will examine the safety and immunogenicity of the omicron-specific vaccine in those who got two doses of the standard Pfizer COVID-19 vaccine. A second group of 600 subjects with three doses of the standard mRNA vaccine will either receive a fourth dose of the omicron-specific formulation or the original formulation. The trials will also check for safety and immune responses in the groups.”

https://www.globalresearch.ca/covid-vaccines-designed-fail-thats-how-they-won-authorization/5768023

“Over the past two years, I’ve been demonstrating that the SARS-CoV-2 virus is a fake. It doesn’t exist. Now let’s enter the bubble where people assume the virus is real, and examine a few of the major crimes and contradictions that exist inside that lunatic bubble.

I wrote and posted this piece while the clinical trials of the COVID vaccine were in progress. It reveals how and why those trials were doomed to fail. They did fail. Since then, nothing has changed.

The vaccine makers DESIGNED a series of clinical trials that, even on their own terms (“the virus is real, fear the virus”) were destined to be a complete flop.

PART ONE:

Peter Doshi, associate editor of the medical journal BMJ, and Eric Topol, Scripps Research professor of molecular medicine, have written a devastating NY Times opinion piece about the ongoing COVID vaccine clinical trials.

They expose the fatal flaw in the large Pfizer, AstraZeneca, and Moderna trials.

September 22, 2020, the Times: “These Coronavirus Trials Don’t Answer the One Question We Need to Know” [1]:

“If you were to approve a coronavirus vaccine, would you approve one that you only knew protected people only from the most mild form of Covid-19, or one that would prevent its serious complications?”

“The answer is obvious. You would want to protect against the worst cases.”

“But that’s not how the companies testing three of the leading coronavirus vaccine candidates, Moderna, Pfizer and AstraZeneca, whose U.S. trial is on hold, are approaching the problem.”

“According to the protocols for their studies, which they released late last week, a vaccine could meet the companies’ benchmark for success if it lowered the risk of mild Covid-19, but was never shown to reduce moderate or severe forms of the disease, or the risk of hospitalization, admissions to the intensive care unit or death.”

“To say a vaccine works should mean that most people no longer run the risk of getting seriously sick. That’s not what these trials will determine.”

This means these clinical trials are dead in the water.

They are only designed to show effectiveness in preventing “mild cases of COVID,” which nobody should care about, because mild cases (cough, fever) naturally run their course and cause no harm. THERE IS NO NEED FOR A VACCINE THAT PREVENTS MILD CASES.

The leading vaccine clinical trials are useless, irrelevant, misleading, and deceptive.

Now let’s go deeper. Read the next section from the Times piece, and then I’ll make comments.

“The Moderna and AstraZeneca studies will involve about 30,000 participants each; Pfizer’s will have 44,000. Half the participants will receive two doses of vaccines separated by three or four weeks, and the other half will receive saltwater placebo shots. The final determination of efficacy will occur after 150 to 160 participants develop Covid-19…”

Here’s how it works. The vaccine companies are looking for a total of 150 mild COVID cases to occur, combined, in the two groups— those receiving the placebo and those receiving the vaccine. How would that happen? The researchers believe “the coronavirus is spreading everywhere” and it will pounce on some of the volunteers in the clinical trial.

Let’s say that, during the trial, 100 people receiving the placebo develop mild COVID-19, and only 50 people receiving the vaccine develop mild COVID.

The vaccine companies would say, “We just proved the vaccine is 50% effective in preventing COVID, and that’s all we need to do, in order to win emergency authorization from the FDA. Release the vaccine. Inject the world.”

The outcomes for 150 people equal “let’s shoot up seven billion people.” That’s staggering.

But it gets even worse. The magic number of 150 COVID cases? How is a COVID case defined? The authors of the Times piece have the answer:

The FDA Cover-up that Led to the Approval of the Pfizer Vaccine

“In the Moderna and Pfizer trials, even a mild case of Covid-19 — for instance, a cough plus a positive lab test — would qualify and muddy the results. AstraZeneca is slightly more stringent but would still count mild symptoms like a cough plus fever as a case.”

But wait. The NY Times itself recently published an article [2] stating that up to 90% of US COVID cases could very well be false positives—in other words, not cases at all. Why? Because the diagnostic PCR test, as it is performed by many labs, is too sensitive. It registers “positive for COVID” when it shouldn’t.

So, in these vaccine clinical trials, the whole process of determining that “150 people developed COVID-19” is completely unreliable, useless, absurd, and nonsensical. On the one hand, a positive PCR test is unreliable and means nothing. On the other hand, a cough and fever (“mild COVID”) are nothing to worry about, and don’t require a vaccine at all. We’re talking about 150 cases of “who cares.” That’s what the COVID vaccine is designed to prevent.

“So the magic number is 150? That’s the number that will decide the immediate fate of the planet?”

“Of course.”

“And these 150 people, who you say develop mild COVID-19…no one should care, because those symptoms cure themselves, and no vaccine is needed.”

“Correct.”

“And come to think of it, the people receiving the vaccine in the clinical trials could develop symptoms indistinguishable from mild COVID-19, as a result of the effects of the vaccine.”

“Yes, that’s right.”

“But you’re very confident in the success of the vaccine.”

“Indeed.”

“Why?”

“I have to be confident. If we’re exposed as incompetent frauds, our bottom line will take a huge hit. And we’ll wind up in prison.”

“Thank you, sir. And that’s tonight’s news. Make sure you take the vaccine, everyone. It’s vital. This is Fred J Clown, for CBS-NBC-ABC-CNN-FOX-PBS-AP-Reuters and all official news sources East, West, North, and South. The News, brought to you by Venom-X-2, a medicine that has only 463 adverse effects. Ask your doctor if Venom is right for you.”

PART TWO: THE DEVIOUS TRICK:

Now I’m going to go over the vital information again, but this time I’m going to show you how…

The vaccine companies can use the fatal flaw in their protocol design to…

Actually win approval of their COVID vaccine.

Stick with me. This is big.

Only 150 people are needed to make the major clinical trials of a COVID vaccine look like a success.

Out of 30,000 volunteers in a trial, researchers are waiting for 150 people to “come down with COVID-19.” MILD cases. They assume this will happen because they believe the coronavirus is everywhere, and it’ll infect their volunteers.

Of course, their definition of a mild case of COVID-19 is meaningless. Cough plus fever, and a positive PCR test. The test spits out false positives like a rigged slot machine, and the visible mild symptoms could result from flu, polluted air, or too many candy bars.

Nevertheless, the researchers are waiting for a total of 150 people to “catch a mild case of COVID.” When that number is reached, everything stops.

Now comes the big moment. How many of those 150 COVID cases occurred in the group that received the vaccine, and how many in the group that received the placebo shot of salt water?

Let’s say only 50 COVID cases occurred in the vaccine group, and 100 in the placebo group. The researchers pop champagne corks. They say, “Look, the vaccine is 50% effective at preventing COVID, and that’s all we need to win emergency authorization from the FDA.”

BUT suppose 75 cases occurred in the vaccine group and 75 in the placebo group? No good. No good at all. No way to call the vaccine effective.

Now comes the “reshaping of the data.”

HERE WE GO.

The researchers say, “Wait. Thirty of the COVID cases in the vaccine group were REALLY just adverse reactions to the vaccine. They weren’t cases of COVID. You see, the vaccine can cause symptoms that are indistinguishable from mild COVID. Cough, fever, chills. ACTUALLY, there were only 40 cases of COVID in the vaccine group. There were 110 in the placebo group. The vaccine IS effective. We’re good. We’re golden. We can get emergency authorization from the FDA right now to shoot up everybody.”

Vaccine manufacturers HAVE KNOWN ALL ALONG that they could pull this trick.

Why leave things to chance?

Why risk a few hundred billion dollars of profit on a random distribution of mild COVID cases among the volunteers in their clinical trials?

The definition of a mild COVID case is EXACTLY what the vaccine manufacturers needed. It enabled them to hatch a plan, to make sure they didn’t fail.

They could pawn off a MILD case of COVID as a reaction to the vaccine. They could fake that without causing ripples. The FDA would say, “The vaccine reactions aren’t serious. All right, no problem. We’ll approve this vaccine for emergency use.”

However…If the manufacturers designed their clinical trial protocol to prevent serious cases of COVID, they would be waiting to see 150 cases of really sick people to occur. That might never happen.

If it did happen, and the manufacturers had to pull their devious switcheroo trick and blame the vaccine for some of these SERIOUS cases…

They would have to tell the FDA that their vaccine was causing life-threatening pneumonia; and the FDA, under a lot of scrutiny these days, would find it very difficult to overlook that.

FDA: “We can’t approve this vaccine. It could cause a few million cases of dire pneumonia…”

The vaccine companies didn’t make a titanic stupid mistake in their protocol design. In gearing the protocol to prevent MILD COVID cases, they did what they did on purpose. It allows them to “reshape their data” and win FDA emergency approval for their vaccine.

These companies have no intention of failing, starting over, and spending a year recruiting 30,000 new volunteers. They want success and money now. They want to win the race.

And they will win, if the truth isn’t known and shared widely.

EPILOGUE:

The punchline.

Every “expert,” in August 2021, is instructed to say the vaccine is definitely protecting people against severe illness and hospitalization. This is their promotional message to the world.

“Yes, even if you’re vaccinated, you could become infected with the virus, you could develop COVID, and you could pass the virus to other people, BUT you must take the shot. It will protect you from becoming severely ill.”

As you can see from what I’ve written above, this is a straight-out lie.

It was always a fantastic lie, from the beginning of COVID vaccine development, because the design of the clinical trials had nothing to do with preventing serious illness.

Notes

[1] nytimes.com/2020/09/22/opinion/covid-vaccine-coronavirus.html

[2] nytimes.com/2020/08/29/health/coronavirus-testing.html